Cancers (ISSN: 2072-6694) is an open access journal, thus granting our readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to cancer therapy in 2024, which are listed below:

1. “Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape”
by Emily Kinsey and Hannah M. Lee
Cancers 2024, 16(3), 666; https://doi.org/10.3390/cancers16030666
Available online: https://www.mdpi.com/2072-6694/16/3/666

2. “Adaptive Radiotherapy: Next-Generation Radiotherapy”
by Olga Maria Dona Lemus, Minsong Cao, Bin Cai, Michael Cummings and Dandan Zheng
Cancers 2024, 16(6), 1206; https://doi.org/10.3390/cancers16061206
Available online: https://www.mdpi.com/2072-6694/16/6/1206

3. “Outcomes and Techniques of Robotic-Assisted Partial Nephrectomy (RAPN) for Renal Hilar Masses: A Comprehensive Systematic Review”
by Savio Domenico Pandolfo, Zhenjie Wu, Riccardo Campi, Riccardo Bertolo, Daniele Amparore, Andrea Mari, Paolo Verze, Celeste Manfredi, Antonio Franco, Francesco Ditonno et al.
Cancers 2024, 16(4), 693; https://doi.org/10.3390/cancers16040693
Available online: https://www.mdpi.com/2072-6694/16/4/693

4. “Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets”
by Greta Pessino, Claudia Scotti, Maristella Maggi and Immuno-HUB Consortium
Cancers 2024, 16(5), 901; https://doi.org/10.3390/cancers16050901
Available online: https://www.mdpi.com/2072-6694/16/5/901

5. “Posterior and Para-Aortic (D2plus) Lymphadenectomy after Neoadjuvant/Conversion Therapy for Locally Advanced/Oligometastatic Gastric Cancer”
by Daniele Marrelli, Stefania Angela Piccioni, Ludovico Carbone, Roberto Petrioli, Maurizio Costantini, Valeria Malagnino, Giulio Bagnacci, Gabriele Rizzoli, Natale Calomino, Riccardo Piagnerelli et al.
Cancers 2024, 16(7), 1376; https://doi.org/10.3390/cancers16071376
Available online: https://www.mdpi.com/2072-6694/16/7/1376

6. “Relationship Between Loss of Y Chromosome and Urologic Cancers: New Future Perspectives”
by Pierluigi Russo, Francesco Pio Bizzarri, Giovanni Battista Filomena, Filippo Marino, Roberto Iacovelli, Chiara Ciccarese, Luigi Boccuto, Mauro Ragonese, Filippo Gavi, Francesco Rossi et al.
Cancers 2024, 16(22), 3766; https://doi.org/10.3390/cancers16223766
Available online: https://www.mdpi.com/2072-6694/16/22/3766

7. “Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer”
by Niraj Neupane, Sawyer Bawek, Sayuri Gurusinghe, Elham Moases Ghaffary, Omid Mirmosayyeb, Sangharsha Thapa, Carla Falkson, Ruth O’Regan and Ajay Dhakal
Cancers 2024, 16(3), 619; https://doi.org/10.3390/cancers16030619
Available online: https://www.mdpi.com/2072-6694/16/3/619

8. “Cutaneous Squamous Cell Carcinoma: An Updated Review”
by Rina Jiang, Mike Fritz and Syril Keena T. Que
Cancers 2024, 16(10), 1800; https://doi.org/10.3390/cancers16101800
Available online: https://www.mdpi.com/2072-6694/16/10/1800

9. “Metal Oxide Nanoparticles as Efficient Nanocarriers for Targeted Cancer Therapy: Addressing Chemotherapy-Induced Disabilities”
by Mohamed Taha Yassin, Fatimah O. Al-Otibi, Sarah A. Al-Sahli, Mohammad S. El-Wetidy and Sara Mohamed
Cancers 2024, 16(24), 4234; https://doi.org/10.3390/cancers16244234
Available online: https://www.mdpi.com/2072-6694/16/24/4234

10. “Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials”
by Jinjiang Wang, Jiaxi Li, Jiao Liu, Kit-Ying Chan, Ho-Sze Lee, Kenneth Nansheng Lin, Chi-Chiu Wang and Tat-San Lau
Cancers 2024, 16(3), 512; https://doi.org/10.3390/cancers16030512
Available online: https://www.mdpi.com/2072-6694/16/3/512

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.